Original article by Dan Harrison
The Sydney Morning Herald – Page: 5 : 20-Aug-14

The Pharmaceutical Society of Australia, the Grattan Institute and others have cited research on the effect of higher prices for prescription drugs in their evidence to a Senate inquiry into a Federal Government plan to lift fees under the Pharmaceutical Benefits Scheme. On 19 August 2014 however, acting Health Department deputy secretary Richard Bartlett rejected claims that the increased charges would lead to some patients opting not to buy the medications prescribed by their doctors. The Government aims to save $A1.3bn over four years

CORPORATES
PHARMACEUTICAL SOCIETY OF AUSTRALIA LIMITED, AUSTRALIA. DEPT OF HEALTH, AUSTRALIAN GREENS, GRATTAN INSTITUTE